Your session is about to expire
← Back to Search
Comprehensive Pre-ESKD Education for Chronic Kidney Disease (TEACH-VET Trial)
N/A
Recruiting
Led By Ashutosh M. Shukla, MD MBBS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Advanced CKD (stage 4 or 5) and not on dialysis
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-48 months
Awards & highlights
TEACH-VET Trial Summary
This trial is testing whether a comprehensive education program can improve care for Veterans with chronic kidney disease.
Who is the study for?
This trial is for Veterans aged 18 or older with advanced chronic kidney disease (stage 4 or 5) who are not on dialysis and receive healthcare from the NF/SG VHS. It excludes non-English speakers, those with dementia, homeless veterans, those in assisted living or nursing homes, and individuals expected to live less than six months.Check my eligibility
What is being tested?
The study tests whether comprehensive pre-end stage renal disease education can improve knowledge of CKD among Veterans and lead to more choosing home dialysis—a better but underused treatment. The impact on patient confidence and health service outcomes will also be evaluated.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medications, there are no direct medical side effects. However, participants may experience stress or anxiety when learning about their condition.
TEACH-VET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidney disease is advanced but I'm not on dialysis.
Select...
I am 18 years old or older.
TEACH-VET Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-48 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-48 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Home Dialysis Use
Secondary outcome measures
Home Dialysis selection
Kidney Disease Knowledge
Satisfaction on Dialysis
+2 moreTEACH-VET Trial Design
2Treatment groups
Active Control
Group I: Comprehensive Pre-ESRD Patient Education (CPE)Active Control1 Intervention
These patients will receive CPE for a total of up to 3 session in an intent-to-teach format, either via Face-to-face or telemedicine delivery.
Group II: Enhanced Usual CareActive Control1 Intervention
This group will receive usual care. This care will be enhanced by providing them with the freely available education material for the Kidney Disease Education
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,304,740 Total Patients Enrolled
Ashutosh M. Shukla, MD MBBSPrincipal InvestigatorNorth Florida/South Georgia Veterans Health System, Gainesville, FL
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Veterans who are expected to live less than 6 months.I am a veteran diagnosed with dementia.Veterans who are homeless or living in assisted living facilities or nursing homes are not eligible.Veterans who are registered to receive healthcare from the NF/SG VHS.Any other specific worries or issues mentioned by the Veteran's healthcare provider.My kidney disease is advanced but I'm not on dialysis.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Comprehensive Pre-ESRD Patient Education (CPE)
- Group 2: Enhanced Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the scope of enrollment for this clinical trial?
"Affirmative. The clinicaltrials.gov website attests that this medical trial, which was initially posted on March 25th 2020, is actively soliciting new candidates. 544 participants are required from 1 site for the study to be completed successfully."
Answered by AI
Does this research endeavor currently allow participants to join?
"Affirmative. Clinicaltrials.gov's information points to this medical trial, which was first published on March 25th 2020, actively recruiting patients. The study aims to recruit 544 participants from 1 location."
Answered by AI
Recent research and studies
Popular Categories
Share this study with friends
Copy Link
Messenger